Evidence map›Paper›PMID 17387594›Full record

ArticleJournal of materials science. Materials in medicine2007

Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combining biphasic calcium phosphate granules and fibrin sealant.

Laurent Le Guehennec, Eric Goyenvalle, Eric Aguado, Paul Pilet, Reiner Spaethe, Guy Daculsi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Preparation of porous apatite granules from calcium phosphate cement.Journal of materials science. Materials in medicine · 2008
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laurent Le GuehennecINSERM, EMI 9903 Materials of Biological Interest, Nantes University, Dental Faculty, place A. Ricordeau, BP 84215, 44042 Nantes Cedex, France.
Eric Goyenvalle
Eric Aguado
Paul Pilet
Reiner Spaethe
Guy Daculsi
Nantes Université · FRBaxter (Austria) · ATHôpital Cardiologique du Haut-Lévêque · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly bioactive biomaterials have been developed to replace bone grafts in orthopedic revision and maxillofacial surgery for bone augmentation. A mouldable, self-hardening material can be obtained by combining TricOs Biphasic Calcium Phosphate Granules and Tissucol Fibrin Sealant. Two components, calcium chloride and antifibrinolytic agents (aprotinin), are essential for the stability of the fibrin clot. The ingrowth of cells in composites combining sealants without calcium chloride or with a low concentration of aprotinin was evaluated in vivo in an experiment on rabbits. Bone colonization was compared using TricOs alone or with the composite made from TricOs and the standard fibrin sealant. Without the addition of calcium chloride, the calcium ions released by the ceramic component interacted with the components of the sealant too late to stabilize the clot. With a low concentration of aprotinin, the degradation of the clot occurred more quickly, leading to the absence of a scaffold on which the bone cells could colonize the composite. Our results indicate that a stable fibrin scaffold is crucial for bone colonization. The low calcium chloride and low aprotinin groups have shown lower bone growth. Further studies will be necessary to determine the minimal amount of antifibrinolytic agent (aprotinin) necessary to allow the same level of osteogenic activity as the TricOs-fibrin glue composite.

Indexed as

AnimalsAprotininBone SubstitutesCalcium ChlorideCalcium PhosphatesDrug CarriersFemaleFemoral FracturesFibrin Tissue AdhesiveFracture HealingMaterials TestingOsseointegrationOsteogenesisRabbitsTreatment OutcomeAprotininBone SubstitutesCalcium Chloridecalcium phosphate, dibasic, anhydrousCalcium PhosphatesDrug CarriersFibrin Tissue Adhesive

Identifiers

PMID17387594
OpenAlexW2051118765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.